Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
Environmental tobacco smoke and peripheral arterial disease: a review
Ngu NL, McEvoy M
(2017), Atherosclerosis, 266, 113-20
Investigation of IRGANOX® 1076 as a dosimeter for clinical X-ray, electron and proton beams and its EPR angular response
Smith C, Ankers E, Best S, Gagliardi F, Katahira K, Tsunei Y, Takahiro T, Geso M
(2017), Rad Phys Chem, 141, 284-91
Real-time in-vivo dosimetry
Beaulieu L, Franich RD, Smith RL
(2017), In: Song WY, Tanderup K, Pieters B (eds), Emerging Technologies in Brachytherapy, CRC Press, Chapter 9,
Stereotactic ablative body radiotherapy for the treatment of spinal oligometastases
Chang JH, Gandhidasan S, Finnigan R, Whalley D, Nair R, Herschtal A, Eade T, Kneebone A, Ruben J, Foote M, Siva S
(2017), Clin Oncol, 29(7), e119-e25
Long-term survivors of glioblastoma: a closer look
Gately L, McLachlan S, Philip J, Ruben J, Dowling A
(2017), J Neurooncol, 136(1), 155-62
The effects of gold nanoparticles concentrations and beam quality/LET on dose enhancement when irradiated with X-rays and protons using alanine/EPR dosimetry
Smith CL, Best SP, Gagliardi F, Tominaga T, Geso M
(2017), Radiat Meas, 106, 352-6
A generic TG-186 shielded applicator for commissioning model-based dose calculation algorithms for high-dose-rate 192 Ir brachytherapy
Ma Y, Vijande J, Ballester F, Tedgren ?C, Granero D, Haworth A, Mourtada F, Fonseca GP, Zourari K, Papagiannis P, Rivard MJ, Siebert FA, Sloboda RS, Smith R, Chamberland MJP, Thomson RM, Verhaegen F, Beaulieu L
(2017), Med Phys, 44(11), 5961-76
DOI: 10.1002/mp.12459
A randomized controlled trial of an additional funding intervention to improve clinical trial enrollment
Parker C, Snyder R, Jefford M, Dilts D, Wolfe R, Millar J
(2017), J Natl Compr Canc Netw, 15(9), 1104-10
Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer
Ong WL, Foroudi F, Evans S, Millar JL
(2017), BJU Int, 120(Suppl 3), 35-42
DOI: 10.1111/bju.13969
3D catheter reconstruction in HDR prostate brachytherapy for pre-treatment verification using a flat panel detector
Smith RL, Haworth A, Panettieri V, Millar JL, Franich RD
(2017), Phys Med, 39, 121-31
Cohort profile: the TrueNTH Global Registry - an international registry to monitor and improve localised prostate cancer health outcomes
Evans SM, Millar JL, Moore CM, Lewis JD, Huland H, Sampurno F, Connor SE, Villanti P, Litwin MS
(2017), BMJ Open, 7(11), e017006
Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
Woodford K, Panettieri V, Tran Le T, Senthi S
(2017), Clin Trans Radiat Oncol, 6, 21-4
Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial
Owen PJ, Daly RM, Livingston PM, Mundell NL, Via JD, Millar JL, Fraser SF
(2017), Trials, 18, 451
Men's perceptions of prostate cancer diagnosis and care: insights from qualitative interviews in Victoria, Australia
Kirkman M, Young K, Evans S, Millar JL, Fisher J, Mazza D, Ruseckaite R
(2017), BMC Cancer, 17, 704
Health-related quality of life for immediate versus delayed androgen-deprivation therapy in patients with asymptomatic, non-curable prostate cancer (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial
Duschesne GM, Woo HH, King M, Bowe SJ, Stockler MR, Ames A, D'Este C, Frydenberg M, Loblaw A, Malone S, Millar J, Tai KH, Turner S
(2017), Lancet Oncol, 18(9), 1192-1201
The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers
Oberoi D, White VM, Seymour JF, Miles Prince H, Harrison S, Jefford M, Winship I, Hill D, Bolton D, Kay A, Millar J, Doo NW, Giles G
(2017), Support Care Cancer, 25(11), 3447-56
Total and beverage-specific alcohol intake and the risk of aggressive prostate cancer: a case-control study
Papa NP, MacInnis RJ, Jayasekara H, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Pedersen J, Severi G, Southey MC, Hopper JL, Giles GG
(2017), Prostate Cancer Prostatic Dis, 20(3), 305-10
DOI: 10.1038/pcan.2017.12
Ejaculatory frequency and the risk of aggressive prostate cancer: findings from a case-control study
Papa NP, MacInnis RJ, English DR, Bolton D, Davis ID, Lawrentschuk N, Millar JL, Pedersen J, Severi G, Southey MC, Hopper JL, Giles GG
(2017), Urol Oncol, 35(8), 530e7-13
Population-based study of grade progression in patients who harboured Gleason 3 + 3
Sampurno F, Earnest A, Millar J, Frydenberg M, Murphy D, Delprado W, Evans S
(2017), World J Urol, 35(11), 1689-99
Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study
White V, Marco DJT, Bolton D, Davis ID, Jefford M, Hill D, Prince HM, Millar JL, Winship IM, Coory M, Giles GG
(2017), BJU Int, 120(Suppl 3), 6-14
DOI: 10.1111/bju.13889